Medical Dynamics

Tylenol Caplet Voluntary Recall Expanded; Consumers Reporting Moldy Smell That Can Cause Nausea, Stomach Pain (The Associated Press)
Bionovo Announces Publication Describing First Novel Dual mTOR Inhibitor, BN107, for the Treatment of Breast Cancer (PR Newswire)
Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai Management anticipates $9 million in 2010 revenues from this initiative (PR Newswire)

Read the rest of this entry »

Sinovac Files Clinical Trial Application with SFDA for Vaccine Against Hand, Foot, and Mouth Disease (PR Newswire)
German Merck sees chemical, pharma acquisitions (Reuters)
Sunesis Pharmaceuticals Regains NASDAQ Compliance (MarketWire)

Read the rest of this entry »

Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex’ Late Stage Innovative Treatment for Multiple Oncology Indications (Press release issued by Teva)

PhRMA Deal Intact As Senate Health Reform Bill Enters Home Stretch (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Crestor Advisory Meeting Weighs Value Of C-Reactive Protein Risk Marker (The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.

Read the rest of this entry »

Cell Therapeutics’ Pixantrone Advisory Committee May Include Updated Results Of Pivotal Trial (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.
Bristol-Myers Squibb and Mead Johnson Announce Preliminary Results of the Exchange Offer (BusinessWire)
New genes for lung disease discovered (Innovations Report)

Read the rest of this entry »

Headache for Addex as migraine study is pulled (PharmaTime)
FDA Gives Emergency Approval for New Swine Flu Test (MedPage Today)
Takeda and Pfizer to Co-Promote Takeda’s Actos® (Pioglitazone HCl) for the Treatment of Type 2 Diabetes in China (Press release issued by Pfizer)

Read the rest of this entry »

“Ipsen establishes optimal biological dose for BN83495 steroid sulphatase (STS) inhibitor in ER-positive metastatic breast cancer” (Press release issued by Ipsen)
“FDA Meets Fewer PDUFA Dates in Fiscal 2008” (FDA News Bulletin)
“EU Pharma Reorganization Leaves Questions About How R&D Will Be Supported” (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Read the rest of this entry »

GSK buys into Intercell, pushes emerging markets and invests more in UK (PharmaTimes)
Lilly puts faith in pipeline but investors get shaky (PharmaTimes)
Is Taxing Plastic Surgery Really an Infringement on Women’s Rights? (AlterNet)

Read the rest of this entry »

Physicians More Likely To Report Drug Safety Information Through Electronic Health Records System (Press release issued by Pfizer)
Novo Nordisk Licenses ZymoGenetics’ IP, Antibody (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.
Novartis presents 6-month results from its EVEREST study for PCV (Medical News.Net)

Read the rest of this entry »

Mammography Imbroglio Makes Case For More Stakeholder Input In CER – AHRQ’s Clancy (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Senate Considers Revised Comparative Effectiveness Plan In Reform Bill (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

FDA Panel To Consider Label Changes For GE, Bayer MRI Drugs (Dow Jones)

Read the rest of this entry »

Pfizer To Present Clinical Data From Expanded Breast Cancer Portfolio At The San Antonio Breast Cancer Symposium (Press release issued by Pfizer)
FDA Approves IV Sildenafil for Hypertension (MedPage Today)
FDA Okays Low-Dose Local Estrogen (MedPage Today)

Read the rest of this entry »